TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

LASIX ONYU

FUROSEMIDE
Cardiovascular Approved 2025-10-07
Jump to: Indications Approvals Trials Competitors Similar Safety Patents
1
Indication
--
Phase 3 Trials
0
Years on Market

Details

Status
Prescription
First Approved
2025-10-07
Routes
SUBCUTANEOUS
Dosage Forms
SOLUTION

Companies

SQ INNOVATION
Active Ingredient: FUROSEMIDE

LASIX ONYU Approval History

Loading approval history...

What LASIX ONYU Treats

2 indications

LASIX ONYU is approved for 2 conditions since its original approval in 2025. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Edema
  • Heart Failure
Source: FDA Label

Drugs Similar to LASIX ONYU

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

ALDACTONE
SPIRONOLACTONE
2 shared
Pfizer
Shared indications:
Heart FailureEdema
CAROSPIR
SPIRONOLACTONE
2 shared
CMP DEV LLC
Shared indications:
Heart FailureEdema
THALITONE
CHLORTHALIDONE
2 shared
CASPER PHARMA LLC
Shared indications:
EdemaHeart Failure
ACETAZOLAMIDE
ACETAZOLAMIDE
1 shared
MANKIND PHARMA
Shared indications:
Edema
ACTIVASE
ALTEPLASE
1 shared
Roche
Shared indications:
Heart Failure
ADREVIEW
IOBENGUANE SULFATE I-123
1 shared
GE HEALTHCARE
Shared indications:
Heart Failure
ATACAND
CANDESARTAN CILEXETIL
1 shared
ANI PHARMS
Shared indications:
Heart Failure
BIDIL
HYDRALAZINE HYDROCHLORIDE
1 shared
AZURITY
Shared indications:
Heart Failure
BUMETANIDE
BUMETANIDE
1 shared
MSN
Shared indications:
Edema
BUMEX
BUMETANIDE
1 shared
VALIDUS PHARMS
Shared indications:
Edema
CANDESARTAN CILEXETIL
CANDESARTAN CILEXETIL
1 shared
MACLEODS PHARMS LTD
Shared indications:
Heart Failure
CARVEDILOL PHOSPHATE
CARVEDILOL PHOSPHATE
1 shared
Sun Pharma
Shared indications:
Heart Failure
COREG
CARVEDILOL
1 shared
WAYLIS THERAP
Shared indications:
Heart Failure
COREG CR
CARVEDILOL PHOSPHATE
1 shared
WAYLIS THERAP
Shared indications:
Heart Failure
DIOVAN
VALSARTAN
1 shared
Novartis
Shared indications:
Heart Failure
DYRENIUM
TRIAMTERENE
1 shared
ADVANZ PHARMA
Shared indications:
Edema
EDECRIN
ETHACRYNIC ACID
1 shared
BAUSCH
Shared indications:
Edema
ENALAPRIL MALEATE
ENALAPRIL MALEATE
1 shared
ALKEM LABS LTD
Shared indications:
Heart Failure
ENBUMYST
BUMETANIDE
1 shared
CORSTASIS THERAP
Shared indications:
Edema
ENTRESTO SPRINKLE
SACUBITRIL
1 shared
Novartis
Shared indications:
Heart Failure
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

LASIX ONYU FDA Label Details

Pro

Indications & Usage

FDA Label (PDF)

Lasix ONYU is a loop diuretic indicated for the treatment of edema in adult patients with chronic heart failure. 1.1 Congestion Lasix ONYU is indicated for the treatment of edema in adult patients with chronic heart failure.

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

FDA Approval: NDA217294 → Label: DailyMed → Patents: FDA Orange Book → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.